KRAS and neoplasm: In relation to this, it was also shown that in non-small-cell lung cancer, oncogenic KRAS alters asparagine biosynthesis via the oxidative stress-responsive NRF2 and ATF4 transcription factors, to suppress apoptosis in response to glutamine deprivation and to sustain tumor growth39.